When it comes to biotech startups, there is no more exciting time than right now. With advances in technology and an ever-growing appetite. for new and innovative products, the biotech industry is booming. And if you are looking to get your foot in the door and invest in some of the most promising startups out there. look no further than Synchron Series Khosla Venturesparkfiercebiotech. This program provides budding biotech entrepreneurs with the resources. they need to take their businesses to the next level. From office space to mentorship from some of the leading minds in the industry.. this program is everything you need to take your business to the next level
Background of Synchron Series Khosla Venturesparkfiercebiotech
Synchron Series Khosla VenturesparkFierceBiotech is an accelerator and investment program. that provides early-stage biotech companies with access to seed funding. mentorship, and industry expertise from some of the leading minds in the field. The accelerator founded by San Francisco venture capitalists Rajesh Khosla and Vinod Khosla. co-founders of Sun Microsystems.
Since its the beginning in 2011. Synchron Series Khosla VenturesparkFierceBiotech has incubated more than 60 startups. including several billion-dollar businesses such as Amgen (NASDAQ:AMGN) Regeneron. Pharmaceuticals (NYSE:REGN) and Vertex Pharmaceuticals (NASDAQ:VRTX). These companies have collective generated more than $11 billion in revenue. and saved countless lives through innovative new therapies.
The Synchron Series Khosla VenturesparkFierceBiotech program. brings together a unique mix of resources that can early. the growth of early-stage biotech companies. The program offers startups access to seed funding ($200,000 to $1 million). mentorship from some of the world’s top investors and entrepreneurs. and industry experience from some of the most experienced leaders in biotechnology.
besides that to providing startup companies with seed funding and mentorship. Synchron Series Khosla VenturesparkFierceBiotech also offers members access to key. resources such as office space networking events, research facilities and consulting services. This combination of
What is the Synchron Series Khosla Venturesparkfiercebiotech?
Synchron Series Khosla Venturesparkfiercebiotech is a new accelerator. program that will help some of the most promising . biotech startups to reach their full potential. The goal of this program is to help these startups become successful companies. and to improve the quality of life for people around the world.
The first cohort of startups will accepted into the program in early 2016. and there are already several incredible companies waiting to join. These companies include Synaptics, which is developing. technology that will make it easier for people to use touch screens . and Modular Biosystems which is working on technologies. that can help hospitals reduce costs and Improve patient care.
The Synchron Series Khosla Venturesparkfiercebiotech is a fantastic opportunity. for these startups and we excited to involved.
Criteria for admission into the Synchron Series Khosla Venturesparkfiercebiotech
We want to admit the best, brightest and most ambitious biotech. startups into our Synchron Series. believe that these startups have the potential to change the world. and we committed to helping them achieve their goals.
To accepted into the series a startup must meet three criteria: 1). be founded by a team of exceptional individuals; 2) have groundbreaking. innovation in its technology or product; and 3) have the potential to become a global leader in its field.
besides that to meeting these criteria, we also in need. edthat startups present a clear business model and strategy. This includes understanding who your target market is and how you plan to reach them. Furthermore, they must have a detailed roadmap detailing. how they will achieve profitability and scalability.